Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke (NETs)
Primary Purpose
Acute Stroke
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Sample of Blood
Sponsored by
About this trial
This is an interventional basic science trial for Acute Stroke focused on measuring Neutrophil extracellular traps, stroke
Eligibility Criteria
Inclusion Criteria:
- Patients ("Patients" + "Patients control" groups) :
Inclusion-1st sample of blood : every patient recruited within the neurovascular unit of intensive care of the Hospital center Sainte - Anne within the framework of a "thrombolyse alert ".
Then pursuit of the study ("patients" group only) if :
- Age 18 minimum
- Sylvien Infarct proved by the intellectual MRI,
- Whatever is the treatment received (Aspegic, thombolysis and/or thrombectomy)
- That there is occlusion of a cerebral artery or not "Controls" group :
- Healthy subjects,
- Mated on the age and the vascular risk factors (tobacco, arterial high blood pressure, diabetes and dyslipidémie)
Exclusion Criteria:
- Patients:
Contraindications in the intravenous thrombolysis according to the current recommendations .
- Controls:
- Histories of evolutionary pathology or thrombo-embolique, taken by treatment whatever it is except contraceptive for the women, the viral or bacterial infection in the month precedents
Sites / Locations
- Centre Hospitalier Sainte-Anne
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Active Comparator
Arm Label
Patients
Patients control
Control (healthy person)
Arm Description
Samples of blood at H0, H+6, H+24 and H+72
Samples of blood at H0
Samples of blood at H0
Outcomes
Primary Outcome Measures
Rate of recanalisation
Correlation between NETs and stroke severity
Secondary Outcome Measures
Thrombus size on MRI
Correlation between NETs and stroke severity
Stroke volume on MRI
Correlation between NETs and stroke severity
Full Information
NCT ID
NCT02476188
First Posted
June 11, 2015
Last Updated
October 18, 2017
Sponsor
Centre Hospitalier St Anne
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, University of Paris 5 - Rene Descartes
1. Study Identification
Unique Protocol Identification Number
NCT02476188
Brief Title
Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke
Acronym
NETs
Official Title
Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke
Study Type
Interventional
2. Study Status
Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
July 31, 2015 (Actual)
Primary Completion Date
August 2016 (Actual)
Study Completion Date
November 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier St Anne
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, University of Paris 5 - Rene Descartes
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study was to investigate the correlation between the nucleosome concentration and the rate of recanalization after thrombolysis. All patients were admitted to the Stroke Unit at the University Hospital Sainte-Anne where they received standard stroke care. The investigators included all patients treated or not by intravenous thrombolysis for anterior circulation stroke with or without vessel occlusion. Exclusion criteria were neoplasms, chronic inflammatory diseases and cytostatic therapy at the time of stroke and stroke-specifics symptoms that had started earlier than 4.5 hours before admission.
Detailed Description
Neutrophil extracellular traps (NETs) were measured in serum at the time of hospitalization, then at 4 hours, 24 hours and 72 hours after stroke. Because of nucleosome instability, a strict preanalytical protocol was followed. Blood samples were centrifuged within 1-2 h after blood drawing. A strict preanalytical protocol was followed including early centrifugation of the samples and storage at - 80°C. NETs were quantified in batches containing all samples from a patient using the detection of MPO (myeloperoxidase) then the Cell-Death-Detection ELISAPLUS (Roche Diagnostics, Germany) as described earlier. Nucleosomes were quantified in relative arbitrary units (AU). Blood samples from each patient were measured within the same run to improve the comparability of the results.
For statistical analysis, various variables of nucleosomes were considered, such as the absolute concentrations determined at admission, at 24 hours and at 72 hours after stroke. Influence of nucleosome concentration on recanalization was tested. Continuous correlations of nucleosomes and infarction volume, nucleosomes and clot size, as well as of infarction volume and NIHSS were calculated by Spearman's rank correlation together with the 95% confidence interval. A p value < 0.05 was considered statistically significant.
The extent of the morphological damage was determined at time of admission to the hospital and 24 hours after thrombolysis by diffusion-weighted magnetic resonance imaging (MRI). The pretreat¬ment and follow-up DWI lesions was segmented using interactive tools based on DWI signal intensity thresholding within a 3-dimensional mask encompassing the apparent area of bright DWI signal intensity and morphometric filtering. The clot location and length were assessed on the susceptibility vessel sign on T2* as describe earlier.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Stroke
Keywords
Neutrophil extracellular traps, stroke
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
124 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patients
Arm Type
Experimental
Arm Description
Samples of blood at H0, H+6, H+24 and H+72
Arm Title
Patients control
Arm Type
Experimental
Arm Description
Samples of blood at H0
Arm Title
Control (healthy person)
Arm Type
Active Comparator
Arm Description
Samples of blood at H0
Intervention Type
Procedure
Intervention Name(s)
Sample of Blood
Primary Outcome Measure Information:
Title
Rate of recanalisation
Description
Correlation between NETs and stroke severity
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Thrombus size on MRI
Description
Correlation between NETs and stroke severity
Time Frame
24 hours
Title
Stroke volume on MRI
Description
Correlation between NETs and stroke severity
Time Frame
24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients ("Patients" + "Patients control" groups) :
Inclusion-1st sample of blood : every patient recruited within the neurovascular unit of intensive care of the Hospital center Sainte - Anne within the framework of a "thrombolyse alert ".
Then pursuit of the study ("patients" group only) if :
Age 18 minimum
Sylvien Infarct proved by the intellectual MRI,
Whatever is the treatment received (Aspegic, thombolysis and/or thrombectomy)
That there is occlusion of a cerebral artery or not "Controls" group :
Healthy subjects,
Mated on the age and the vascular risk factors (tobacco, arterial high blood pressure, diabetes and dyslipidémie)
Exclusion Criteria:
Patients:
Contraindications in the intravenous thrombolysis according to the current recommendations .
Controls:
Histories of evolutionary pathology or thrombo-embolique, taken by treatment whatever it is except contraceptive for the women, the viral or bacterial infection in the month precedents
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michel PLOTKINE, PhD
Organizational Affiliation
University of Paris 5 - Rene Descartes
Official's Role
Study Director
Facility Information:
Facility Name
Centre Hospitalier Sainte-Anne
City
Paris
ZIP/Postal Code
75014
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
11522104
Citation
Holdenrieder S, Stieber P, Bodenmuller H, Fertig G, Furst H, Schmeller N, Untch M, Seidel D. Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med. 2001 Jul;39(7):596-605. doi: 10.1515/CCLM.2001.095.
Results Reference
background
PubMed Identifier
16040855
Citation
Holdenrieder S, Stieber P, Chan LY, Geiger S, Kremer A, Nagel D, Lo YM. Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. Clin Chem. 2005 Aug;51(8):1544-6. doi: 10.1373/clinchem.2005.049320. No abstract available.
Results Reference
background
PubMed Identifier
24146915
Citation
Naggara O, Raymond J, Domingo Ayllon M, Al-Shareef F, Touze E, Chenoufi M, Gerber S, Mellerio C, Zuber M, Meder JF, Mas JL, Oppenheim C. T2* "susceptibility vessel sign" demonstrates clot location and length in acute ischemic stroke. PLoS One. 2013 Oct 11;8(10):e76727. doi: 10.1371/journal.pone.0076727. eCollection 2013.
Results Reference
background
Learn more about this trial
Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke
We'll reach out to this number within 24 hrs